Company / Return on Equity (ROE)
ENvue Medical, Inc. Return on Equity (ROE) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-590.9%
FY2025
5-year range
-590.9% / -93.0%
FY2021-FY2025
Trend
-535.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
ENvue Medical, Inc. reports negative total equity of -590.9% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-590.9% in FY2025 with a 5-year CAGR of -161.1%.
Declined from -168.5% to -590.9% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -364.7pp
- 5-Year Change
- -161.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 535.0% year-over-year.
- Peak return on equity (roe) was recorded in FY2017.
- Lowest return on equity (roe) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -590.9% | -535.0% |
| FY2024 | -93.0% | +44.8% |
| FY2023 | -168.5% | +25.5% |
| FY2022 | -226.2% | -25.2% |
| FY2021 | -180.7% | +58.0% |
| FY2020 | -429.8% | +52.1% |
| FY2019 | -897.2% | -556.7% |
| FY2018 | -136.6% | -75.4% |
| FY2017 | -77.9% | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026